March 26, 2015 — Edwards Lifesciences Corp. announced that chairman and CEO Michael A. Mussallem served as an invited ...
Heart Valve Technology
This channel includes news and new device innovations about heart valve technologies, including the aortic valve, mitral valve, pulmonic valve, and tricuspid valve. This includes information on transcatheter valve technologies like transcatheter aortic valve replacement (TAVR, or implantation TAVI), transcatheter mitral valve repair or replacement (TMVR), transcatheter and surgical valve repairs, and surgical replacement valves. Newer devices are now being used for transcatheter tricuspid valve repair replacement (TTVR).
March 26, 2015
March 26, 2015 — Research and consulting firm GlobalData reported that the global market value for transcatheter heart ...
March 26, 2015The biggest technology news coming out of the 2015 American College of Cardiology (ACC) annual scientific sessions ...
March 26, 2015
March 25, 2015 — A new expert consensus paper released by a coalition of cardiovascular organizations provides guidance ...
March 25, 2015
March 25, 2015 — The Sapien 3 heart valve (Edwards Lifesciences) demonstrated lower death, stroke and paravalvular leak ...
March 25, 2015
March 23, 2015 — A detailed reporting of the first successful case of a direct transcatheter tricuspid repair (TTVR) for ...
March 23, 2015
March 20, 2015 —The commercial track record with transcatheter mitral valve repair, approved for patients at high risk ...
March 20, 2015
Several late-breaking trials for transcatheter aortic valve replacement (TAVR) were presented at the American College of ...
March 20, 2015
March 19, 2015 — An investigational device that deflects debris away from the brain during transcatheter aortic valve ...
March 19, 2015
March 18, 2015 — New study results from The Cardiothoracic Surgical Trials Network (CTSN) show the addition of surgical ...
March 18, 2015
Feature | Gregory Chodaczek, analyst for Sterne Agee
March 17, 2015 — The American College of Cardiology (ACC) hosted its 64th Annual Scientific Session & Expo over the ...
March 17, 2015
March 17, 2015 — New two-year data from the CoreValve U.S. Pivotal High Risk Study, which demonstrated superior two-year ...
March 17, 2015
March 17, 2015 — Five-year data suggest that the Sapien transcatheter heart valve (Edwards Lifesciences) is a feasible ...
March 17, 2015
Feature | Gregory Chodaczek, analyst for Sterne Agee
Key data from many transcatheter aortic valve replacement (TAVR) clinical trials will be presented as late-breakers at ...
March 11, 2015
March 10, 2015 — In an analysis of outcomes of about 12,000 patients who underwent transcatheter aortic valve ...
March 10, 2015